Read + Share
Amedeo Smart
Independent Medical Education
Cerono G, Cree BAC, Hauser SL, Baranzini SE, et al. Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence. Ann Neurol 2025 Sep 8. doi: 10.1002/ana.78033.PMID: 40919837
Email
LinkedIn
Privacy Policy